scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S1052-5157(18)30322-2 |
P698 | PubMed publication ID | 8995112 |
P50 | author | Paul Moayyedi | Q28039220 |
P2093 | author name string | Dixon MF | |
P2860 | cites work | Cure of duodenal ulcer associated with eradication of Helicobacter pylori | Q28256637 |
Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy | Q28326596 | ||
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration | Q29547429 | ||
Helicobacter pylori infection and the risk of gastric carcinoma | Q29618446 | ||
Campylobacter pylori: its link to gastritis and peptic ulcer disease. | Q30457021 | ||
Twenty years' screening for cancer of the uterine cervix in Great Britain, 1964-84: further evidence for its ineffectiveness | Q33686693 | ||
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo | Q34377875 | ||
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer | Q34378029 | ||
The urea breath test for Helicobacter pylori | Q34379155 | ||
Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study | Q34381165 | ||
Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. | Q34393848 | ||
Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. | Q34394938 | ||
Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology | Q34395090 | ||
Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up | Q34395562 | ||
Early gastric cancer: 46 cases treated in one surgical department | Q34396484 | ||
Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis | Q34532464 | ||
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii | Q34598713 | ||
Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation | Q34621164 | ||
Anxiety caused by abnormal result of cervical smear test: a controlled trial | Q35167971 | ||
Screening in practice: Reducing the psychological costs | Q35169855 | ||
Early detection of gastric cancer | Q35170559 | ||
Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia | Q35181513 | ||
Gastric cancer: a curable disease in Britain | Q35189697 | ||
Prevalence of symptoms of dyspepsia in the community | Q35706989 | ||
Breast screening: time for a rethink? | Q35718199 | ||
Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large | Q35991490 | ||
Helicobacter pylori: the African enigma | Q36096198 | ||
Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. | Q36598458 | ||
Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population | Q36598749 | ||
Laser-based analysis of carbon isotope ratios | Q36762919 | ||
Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class | Q36824852 | ||
Helicobacter pylori infection in childhood: risk factors and effect on growth | Q36888795 | ||
Accuracy of serology for the diagnosis of Helicobacter pylori infection--a comparison of eight kits | Q37217077 | ||
Helicobacter pylori and peptic ulceration: histopathological aspects | Q37362501 | ||
Helicobacter pylori therapy: effect on peptic ulcer disease | Q37362515 | ||
Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis | Q37620885 | ||
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors | Q37886448 | ||
Screening for gastric cancer | Q38638367 | ||
Gastric cancer: a 25-year review | Q38943173 | ||
A model for gastric cancer epidemiology | Q39333565 | ||
Controversy in the detection of disease | Q39342395 | ||
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 | Q39605655 | ||
Mucin exocytosis: a major target for Helicobacter pylori | Q39610750 | ||
Non-ulcer dyspepsia: potential causes and pathophysiology | Q39641283 | ||
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. | Q40269713 | ||
Review article: Helicobacter pylori eradication--understandable caution but no excuse for inertia | Q40647772 | ||
Eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. | Q40711481 | ||
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials | Q41018165 | ||
Factors influencing the eradication of Helicobacter pylori with triple therapy | Q41123623 | ||
Gastric adenocarcinoma and Helicobacter pylori infection | Q41146579 | ||
Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils | Q42005109 | ||
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy | Q42271465 | ||
Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations | Q43213088 | ||
13C-urea breath test for Helicobacter pylori infection | Q43220311 | ||
Helicobacter pylori in the stomach--a paradox unmasked | Q43797208 | ||
Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer | Q44007088 | ||
Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach | Q44246799 | ||
The risk of stomach cancer in patients with gastric or duodenal ulcer disease | Q44760814 | ||
Age-dependent increase of Campylobacter pylori antibodies in blood donors | Q44928567 | ||
Development of a mouse model of Helicobacter pylori infection that mimics human disease | Q44933673 | ||
Antral atrophy, Helicobacter pylori colonization, and gastric pH. | Q45140350 | ||
Long-term sequelae of Helicobacter pylori gastritis. | Q50597465 | ||
Observer variation in the assessment of chronic gastritis according to the Sydney system. | Q50769005 | ||
Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. | Q52869702 | ||
Ascorbic acid: a factor concentrated in human gastric juice. | Q52876721 | ||
Changing demographics of peptic ulcer disease. | Q55061135 | ||
An international association between Helicobacter pylori infection and gastric cancer | Q57980857 | ||
H pylori and gastric cancer | Q60386614 | ||
Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy | Q61537788 | ||
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists | Q64136135 | ||
Increased absenteeism from work after detection and labeling of hypertensive patients | Q67381644 | ||
Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study | Q68050167 | ||
A comparison of diagnostic tests to determine Helicobacter pylori infection | Q68104722 | ||
Estimates of the worldwide frequency of sixteen major cancers in 1980 | Q68257962 | ||
Evidence for weakening of gastric mucus integrity by Campylobacter pylori | Q68458875 | ||
Risk factors of gastric precancerous lesions in a high-risk Colombian population. I. Salt | Q68702943 | ||
Activated neutrophils induce prolonged DNA damage in neighboring cells | Q69843255 | ||
A long-term follow-up study of patients with gastric cancer detected by mass screening | Q69941628 | ||
Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes | Q70305064 | ||
Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry | Q70560864 | ||
Helicobacter pylori infection and gastric cancer | Q71398585 | ||
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection | Q71699036 | ||
Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample | Q71821292 | ||
Transmission of Helicobacter pylori infection | Q72053728 | ||
Acid, ulcers, and H pylori | Q72227276 | ||
Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy | Q72363101 | ||
Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia | Q72388090 | ||
Should general surgeons treat gastric carcinoma? An audit of practice and results, 1980-1985 | Q72399371 | ||
High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients | Q72660583 | ||
Therapeutic immunisation against Helicobacter infection | Q72673255 | ||
Scoliosis screening: a pause in the chase | Q93642524 | ||
P433 | issue | 1 | |
P921 | main subject | Helicobacter pylori | Q180556 |
Helicobacter pylori infectious disease | Q4497153 | ||
P304 | page(s) | 47-64 | |
P577 | publication date | 1997-01-01 | |
P1433 | published in | Gastrointestinal endoscopy clinics of North America | Q26842413 |
P1476 | title | Significance of Helicobacter pylori infection and gastric cancer: implications for screening | |
P478 | volume | 7 |
Q36145289 | Geographical distribution of the incidence of gastric cancer in Bhutan. |
Q24186365 | Helicobacter pylori eradication for the prevention of gastric neoplasia |
Q24245327 | Helicobacter pylori eradication for the prevention of gastric neoplasia |
Q39067619 | Population screening and treatment of Helicobacter pylori infection |
Search more.